News preview — no account needed

BlueWind Medical Wins FDA Clearance for 15-Year Tibial Neuromodulation Implant

Medical Economics · August 5, 2026

Preview

BlueWind Medical received FDA 510(k) clearance for Revi Extend, a next-generation version of its implantable tibial neuromodulation device for urgency urinary incontinence, extending the device's functional life from 10 to 15 years. The implant sits near…

The complete summary, “why it matters” analysis and the original source link are available to members.

NeurostimulationNeural Implant